GenomeMe Lab Inc. products

The GeneNav™ HPV Complete qPCR Kit utilizes quantitative PCR (qPCR) technology to detect all 14 High Risk human papilloma virus (HPV) subtypes, allowing physicians to identify those at risk for cervical cancer. In addition, HPV Complete enables detection of HPV types 6 and 11 which are considered low risk for cervical cancer, however they are the cause of 90% of all cases of genital warts as well as respiratory papillomatosis.  This in vitro diagnostic kit allows for simultaneous detection of HPV 16 or HPV 18, nonspecific pooled detection of the other 12 high risk HPV subtypes (HPV 31, HPV 33, HPV 35, HPV 39, HPV 45, HPV 51, HPV 52, HPV 56, HPV 58, HPV 59, HPV 66, and HPV 68), and simultaneous detection of low-risk subtypes HPV 6 or 11. A human β-Actin internal control is also used in the GeneNav™ HPV Complete qPCR Kit to assess specimen quality and ensure the reliability of the HPV detection results.

The GeneNav™ HPV One qPCR Kit is designed for quick initial screening of individuals for the presence of all 14 High Risk human papilloma virus (HPV) subtypes allowing physicians to identify those at risk for cervical cancer. This in vitro diagnostic kit allows for the specific detection and discrimination between HPV 16, HPV 18, and nonspecific pooled detection of the other 12 high risk HPV subtypes (HPV 31, HPV 33, HPV 35, HPV 39, HPV 45, HPV 51, HPV 52, HPV 56, HPV 58, HPV 59, HPV 66, and HPV 68). A human β-Actin internal control is also used in the GeneNav™ HPV One qPCR Kit to assess specimen quality and ensure the reliability of the HPV detection results.